
NIH spotlights trio of academic teams chasing after 'pan-coronavirus' vaccines
Having made loud and clear its call for new research on vaccines that can tackle future pandemics, the NIH is shedding light on some of the projects it’s funding.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded around $36.3 million to three academic groups that are working on developing “pan-coronavirus vaccines” — inoculations that can protect against a diverse family of coronaviruses, especially the voracious ones like SARS-CoV-2.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.